Roles of the metallothionein family of proteins in the central nervous system

Brain Research Bulletin

Volumn 55, Issue 2, 2001, Pages 133-145

  Hidalgo, Juan ^a   Aschner, Michael ^b   Zatta, Paolo ^c   Vašák, Milan ^d  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Copper; Metal thiolate complexes; Neurodegenerative diseases; Oxidative stress; Zinc

Indexed keywords

COPPER; CYSTEINE; GROWTH INHIBITOR; METALLOTHIONEIN; PROTEIN; REACTIVE OXYGEN METABOLITE; ZINC;

ADAPTATION; AGING; ALZHEIMER DISEASE; CONFERENCE PAPER; COPPER METABOLISM; DEGENERATIVE DISEASE; DETOXIFICATION; EPITHELIUM; HUMAN; KERATINIZATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REGULATORY MECHANISM; STRESS; ZINC METABOLISM;

ANIMALS; CENTRAL NERVOUS SYSTEM; COPPER; HUMANS; METALLOTHIONEIN; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PROTEIN ISOFORMS; ZINC;

EID: 0035872463     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00452-X     Document Type: Conference Paper

References (213)

1. Expression of growth inhibitory factor (metallothionein-III) mRNA and protein following excitotoxic immature brain injury
2. Primary cortical glial reaction versus secondary thalamic glial response in the excitotoxically injured young brain: Astroglial response and metallothionein expression
3. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease
4. Metallothionein-I+II induction by zinc and copper in primary cultures of rat microglia
5. Regulation of metallothionein-III (GIF) mRNA in the brain of patients with Alzheimer disease is not impaired
6. Expression of human metallothionein-III confers protection against serum-free exposure of stably transfected Chinese hamster ovary CHO-K1 cells
7. Regulation of metallothionein gene expression by oxidative stress and metal ions
8. Expression of growth inhibitory factor (GIF) in normal and injured rat brains
9. Nitric oxide induces Zn2+ release from metallothionein by destroying zinc-sulphur clusters without concomitant formation of S-nitrosothiol
10. Three-dimensional structure of rabbit liver [Cd7]metallothionein-2a in aqueous solution determined by nuclear magnetic resonance
11. Induction of metallothionein by diethyl maleate
12. Effect of stress on mouse and rat brain metallothionein I and III mRNA levels
13. Metallothionein: Molecular evolution and classification
14. Expression of different metallothionein messenger ribonucleic acids in motor cortex, spinal cord and liver from patients with amyotrophic lateral sclerosis
15. Distribution of metallothionein in the human central nervous system
16. Localization of metallothionein in the mammalian central nervous system
17. Structural characterization of Cu(I) and Zn(II) sites in neuronal-growth-inhibitory factor by extended X-ray absorption fine structure (EXAFS)
18. Evidence for Cu(I) clusters and Zn(II) clusters in neuronal growth-inhibitory factor isolated from bovine brain
19. Comparison of the NMR solution structure and the X-ray crystal structure of rat metallothionein-2
20. Interactions between metallothionein and trace elements
21. Growth inhibitory factor and zinc affect neural cell cultures in a tissue specific manner
22. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells
23. Modulation of A beta adhesiveness and secretase site cleavage by zinc
24. Neurologic disease in transgenic mice by cerebral overexpression of interleukin 6
25. Metallothionein (MT)-III: Generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains
26. Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-α
27. Interleukin-6 and tumor necrosis factor-alpha type 1 receptor deficient mice reveal a role of IL-6 and TNF-alpha on brain metallothionein-I and -III regulation
28. Localization of metallothionein-I and -III expression in the CNS of transgenic mice with astrocyte-targeted expression of interleukin 6
29. Enhanced seizures and hippocampal neurodegeneration following kainic acid induced seizures in metallothionein-I+II deficient mice
30. Structural and functional analysis of the rat metallothionein III genomic locus
31. The significance of the nuclear and cytoplasmic localization of metallothionein in human liver and tumor cells
32. Constitutive expression of metallothionein genes in mouse brain
33. Enhanced metallothionein gene expression is associated with protection from cadmium-induced genotoxicity in cultured rat liver cells
34. Absorption, transport, and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin
35. Zinc metabolism in the brain: Relevance to human neurodegenerative disorders
36. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements
37. Activation of the chicken metallothionein promoter by metals and oxidative stress in cultured cells and transgenic mice
38. Temporalspatial patterns of expression of metallothionein-I and -III and other stress related genes in rat brain after kainic acid-induced seizures
39. Oxidative stress activates metal-responsive transcription factor-1 binding activity. Occupancy in vivo of metal response elements in the metallothionein-I gene promoter
40. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material
41. Endotoxin induction of murine metallothionein gene expression
42. Immunocytochemical detection of metallothionein (MT1 and MT2) in copper-enhanced sheep brains
43. Metallothionein
44. Expression and regulation of brain metallothionein
45. Disruption of the metallothionein-III gene in mice: Analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures
46. Expression of human metallothionein-III in transgenic mice
47. Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF)
48. Evidence for a dynamic structure of human neuronal growth inhibitory factor and for major rearrangements of its metal-thiolate clusters
49. Distinct metal-thiolate clusters in the N-terminal domain of neuronal growth inhibitory factor
50. Neuroinflammatory processes are important in neurodegeneratives: An hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development
51. Translocation of zinc may contribute to seizure-induced death of neurons
52. Importance of zinc in the central nervous system: The zinc-containing neuron
53. Metallothionein protects against cerulein-induced acute pancreatitis: Analysis using transgenic mice
54. Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines
55. Expression of MT-3 protein in the human kidney
56. Regulation of metallothionein-I+II levels in specific brain areas and liver in the rat: Role of catecholamines
57. Astrocyte-targeted expression of interleukin-3 and interferon-α causes specific changes in metallothionein expression in the brain
58. Metallothionein
59. Novel function of metallothionein in photoprotection: Metallothionein-null mouse exhibits reduced tolerance against ultraviolet B injury in the skin
60. Metallothionein mRNA and protein induction by cadmium in peripheral-blood leucocytes
61. Copper-thionein in leucocytes
62. Metal-thiolate clusters in the C-terminal domain of human neuronal growth inhibitory factor (GIF)
63. Effect of the two conserved prolines of the human growth inhibitory factor (metallothionein-3) on its biological activity and structure dynamics: Comparison with a mutant protein
64. Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain
65. A syndrome of acute zinc loss. Cerebellar dysfunction, mental changes, anorexia, and teste and smell dysfunction
66. Transgenic expression of interleukin 6 in the central nervous system regulates brain metallothionein-I and -III expression in mice
67. The transcription factor MTF-1 is essential for basal and heavy metal-induced metallothionein gene expression
68. Transcriptional regulation by heavy metals, examplified at the metallothionein genes
69. Liver, brain, and heart metallothionein induction by stress
70. Regulation of brain metallothioneins
71. Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain
72. Expression of MT-3 mRNA in human kidney, proximal tubule cell cultures, and renal cell carcinoma
73. Localisation and expression of metallothionein immunoreactivity in the developing sheep brain
74. Changes of growth inhibitory factor after stab wounds in rat brain
75. Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds - An immunocytochemical study using confocal laser scan microscope
76. Alzheimer's disease, beta-amyloid protein and zinc
77. Patterns of growth inhibitory factor (GIF) and glial fibrillary acidic protein relative level changes differ following left middle cerebral artery occlusion in rats
78. Bacterial endotoxin-induced expression of metallothionein genes in rat brain, as revealed by in situ hybridization
79. The selective inhibition of hippocampal glutamic acid and decarboxylase in zinc-induced epileptic seizures
80. Induction of metallothionein by stress and its molecular mechanisms
81. Hepatic lysosomal copper protein in dogs with an inherited copper toxicosis
82. Biochemistry of metallothionein
83. Metallothionein: A cadmium- and zinc-containing protein from equine renal cortex. II. Physicochemical properties
84. Metallothionein: A cadmium- and zinc-containing protein from equine renal cortex
85. The antioxidant function of metallothionein in the heart
86. Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity
87. Metallothionein inhibits ischemia-reperfusion injury in mouse heart
88. Metallothioneins: Proteins in search of function
89. Immunohistochemical analysis in a case of idiopathic Lennox-Gastaut syndrome
90. Metallothionein reacts with Fe2+ and NO to form products with Ag = 2.039 ESR signal
91. Neuronal localization of metallothioneins in rat and human spinal cord
92. Molecular cloning of rat growth inhibitory factor cDNA and the expression in the central nervous system
93. The role of zinc in selective neuronal death after transient global cerebral ischemia
94. Protective effect of metallothionein on intracellular pH changes induced by cadmium
95. Molecular cloning and expression of the canine metallothionein-III gene
96. Localization of metallothioneins-I & -II and -III in the brain of aged dog
97. Enhanced apoptosis in metallothionein null cells
98. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein
99. Effect of non-toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide-induced activation
100. Induction of metallothionein mRNA and protein in murine astrocyte cultures
101. Induction of metallothionein mRNA and protein in primary murine neuron cultures
102. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9
103. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes
104. Antisense down-regulation of metallothionein in a human monocytic cell line alters adherence, invasion, and the respiratory burst
105. Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc
106. The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury
107. Activation of the complete mouse metallothionein gene locus in the maternal deciduum
108. The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture
109. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity
110. Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity
111. Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity
112. Copper, iron, and zinc in Alzheimer's disease senile plaques
113. A cadmium protein from equine kidney cortex
114. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium
115. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles
116. Neuroimmune mechanisms in Alzheimer's disease pathogenesis
117. Species differences in the occurrence of copper-metallothionein in the particulate fractions of the liver of copper-loaded animals
118. Accumulation of metallothionein and its multiple forms by zinc, cadmium and dexamethasone in human peripheral T and B lymphocytes and monocytes
119. Amide proton exchange in human metallothionein-2 measured by nuclear magnetic resonance spectroscopy
120. Three-dimensional structure of human [113Cd7]metallothionein-2 in solution determined by nuclear magnetic resonance spectroscopy
121. 7]-metallothionein-2 and [Cd7]-metallothionein-2 using nuclear magnetic resonance spectroscopy
122. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse
123. Evidence that nitric oxide enhances cadmium toxicity by displacing the metal from metallothionein
124. Expression of the gene encoding metallothionein-3 in organs of the reproductive system
125. Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons
126. Alterations of metallothionein II and apolipoprotein J mRNA levels in kainate-treated rats
127. Immunochemical detection of metallothionein in brain
128. Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain
129. Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury
130. Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient
131. MT-III, a brain-specific member of the metallothionein gene family
132. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice
133. Metallothionein genes and their regulation in transgenic mice
134. Induction by zinc of specific metallothionein isoforms in human monocytes
135. Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein
136. Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallothionein-I+II deficient mice
137. CNS wound healing is severely depressed in metallothionein I- and II-deficient mice
138. Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice
139. Impaired inflammatory response to glial cell death in genetically metallothionein-I- and -II-deficient mice
140. The zinc or copper deficiency-induced impaired inflammatory response to brain trauma may be caused by the concomitant metallothionein changes
141. IL-6 deficiency leads to reduced metallothionein-I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment
142. Metallothionein I+II expression and their role in experimental encephalomyelitis
143. Increased astrocytic expression of metallothioneins I+II in brainstem of adult rats treated with 6-aminonicotinamide
144. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures
145. Disruption of the blood-brain interface in neonatal rat neocortex induces a transient expression of metallothionein in reactive astrocytes
146. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice
147. Distribution of metallothionein I+II and vesicular zinc in the developing central nervous system: Correlative study in the rat
148. Macrophages and microglia in the nervous system
149. Om kadmium i normala människonjurar samt redogörelse för isolering av metallothionein ur level fran kadmiumexponerade kaniner
150. Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain
151. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia
152. Metallothionein accumulation in CHO Cdr cells in response to lead treatment
153. Metallothionein induction in neonatal rat primary astrocyte cultures protects against methylmercury cytotoxicity
154. Refined crystal structure of Cd, Zn metallothionein at 2.0 A resolution
155. Metal-specific posttranscriptional control of human metallothionein genes
156. Molecular analyses of metallothionein gene regulation
157. Oxygen free radicals and metallothionein
158. Transient peaks in zinc and metallothionein levels during differentiation of 3T3L1 cells
159. Conformation of [Cd7]-metallothionein-2 from rat liver in aqueous solution determined by nuclear magnetic resonance spectroscopy
160. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide
161. Regulation, linkage, and sequence of mouse metallothionein I and II genes
162. Bioactivity of metallothionein-3 correlates with its novel beta domain sequence rather than metal binding properties
163. Localization of metallothionein-I and -II in hypertrophic astrocytes in brain lesions of dogs
164. An immunohistochemical study on the tissue-specific localization of metallothionein in dogs
165. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis
166. Metallothionein in amyotrophic lateral sclerosis
167. Metallothioneins 1 and 2 are expressed in the olfactory mucosa of mice in untreated animals and during the regeneration of the epithelial layer
168. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor
169. Metallothionein expression is increased in monocytes and erythrocytes of young men during zinc supplementation
170. Metallothionein in developing human brain
171. Localization of metallothionein in aged human brain
172. Astrocyte cultures from transgenic mice to study the role of metallothionein in cytotoxicity of tert-butyl hydroperoxide
173. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals
174. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease
175. Growth inhibitory factor in brain
176. Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases
177. Regulation of growth inhibitory factor expression by epidermal growth factor and interleukin-1β in cultured rat astrocytes
178. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein
179. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia
180. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress
181. Metallothioneins: New functional and structural insights
182. Metallothionein
183. Metal co-ordination in rat liver metallothionein-2 prepared with or without reconstitution of the metal clusters, and comparison with rabbit liver metallothionein-2
184. Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse
185. The distribution of zinc selenite and expression of metallothionein-III mRNA in the spinal cord and dorsal root ganglia of the rat suggest a role for zinc in sensory transmission
186. Metallothionein induction protects swollen rat primary astrocyte cultures from methylmercury-induced inhibition of regulatory volume decrease
187. 2 toxicity
188. Sequence and functional analysis of the 5′-flanking region of the mouse growth inhibitory factor gene
189. Human metallothionein genes: Structure of the functional locus at 16q13
190. The protective effects of zinc on diethyldithiocarbamate cytotoxicity on rat astrocytes in vitro
191. Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel
192. Purification and characterization of glutamate decarboxylase from mouse brain
193. Coordinate regulation of mouse metallothionein I and II genes by heavy metals and glucocorticoids
194. Subcellular localization of growth inhibitory factor in rat brain: Light and electron microscopic immunohistochemical studies
195. Ischemia induces metallothionein III expression in neurons of rat brain
196. Transfection and overexpression of metallothionein-I in neonatal rat primary astrocyte cultures and in astrocytoma cells increases their resistance to methylmercury-induced cytotoxicity
197. Foreign metallothionein-I (MT-I) expression by transient transfection in MT-I and -II null astrocytes confers increased protection against acute methylmercury cytotoxicity
198. Glial metallothionein
199. Glial immunoreactivity for metallothionein in the rat brain
200. Expression of growth inhibitory factor mRNA after focal ischemia in rat brain
201. Expression of growth inhibitory factor mRNA following cortical injury
202. Changes in growth inhibitory factor mRNA expression compared with those in c-jun mRNA expression following facial nerve transection
203. Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease
204. Three-dimensional solution structure of mouse [Cd7]-metallothionein-1 by homonuclear and heteronuclear NMR spectroscopy
205. Chemical modulation of metallothionein I and III mRNA in mouse brain